You searched for "funding"
Metformin, the magical solution!
Both noise-induced hearing loss (NIHL) and vestibular schwannomas (VSs) pose a challenge in terms of management. Metformin was suggested as a potential therapeutic drug for NIHL when the drug-target interaction data was investigated. Additionally, there are studies which demonstrate reduction...
Virtual vestibular rehabilitation (VR) is as effective as in-person VR
The effectiveness of vestibular rehabilitation (VR) for patients with several vestibular disorders is well established. Access for in-person clinic-based VR is however patchy and limited. To widen access, offering VR via virtual platforms is increasingly being adopted. The authors conducted...New TympStar Pro updates including WideBand tympanometry
Grason-Stadler, a worldwide leader of clinical audiometric systems, is pleased to announce new updates to their leading clinical tympanometer, the GSI TympStar Pro™.Accurately diagnosing reflux to direct personalised treatment
Laryngopharyngeal reflux (LPR) frequently causes severe extra-gastrointestinal symptoms – such as a persistent cough, vocal problems, asthma or difficulty swallowing – that can be easily confused with a common cold and allergies.Signia UK enters into partnership with The Audiology Academy
Today, Signia UK and The Audiology Academy have announced an exclusive partnership designed with the intention to create better access to high quality training for Hearing Care Professionals in the UK.VACANCY: Audiology Partner – Pontypridd
Take on this existing successful business and make it grow, look after your private customers, serve your community, create an asset for your family’s future and enjoy the profits of all your hard work.
Bevacizumab, NF2, hearing and age
Introduction NF2-related schwannomatosis (NF2-SWN) is an autosomal dominant disorder leading to the development of schwannomas, meningiomas and spinal cord ependymomas. Younger age is a negative prognostic factor. Treatment includes observation, surgery, radiotherapy and medical therapy with bevacizumab (VEGF monoclonal antibody)....Innovative approaches to treating deafness
Shahar Taiber and Karen Avraham give us a summary of gene therapies for hearing loss, with an overview of limitations and what the future holds. Hearing loss is the most common sensory disorder. The last two decades have seen a...
